ABUS vs REGN: Which Stock is Better?

Side-by-side comparison of Arbutus Biopharma Corp and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ABUS

Arbutus Biopharma Corp

$4.21

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricABUSREGNWinner
Market Cap$780.84M$77.69BREGN
P/E RatioN/A17.57REGN
EPS (TTM)$N/A$41.71REGN
Revenue Growth-0.6%0.0%REGN
Gross Margin-98.9%45.8%REGN

Analyze ABUS

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ABUS or REGN a better investment?

Comparing ABUS and REGN: Arbutus Biopharma Corp has a market cap of $780.84M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ABUS and REGN?

ABUS (Arbutus Biopharma Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ABUS or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ABUS or REGN?

REGN has higher revenue growth at 0.0% vs -0.6% for ABUS.

Which company is more profitable: ABUS or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -98.9% for ABUS.

Which is the larger company: ABUS or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $780.84M for ABUS.

Should I buy ABUS or REGN in 2026?

Both ABUS and REGN have investment merit. ABUS trades at $4.21 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ABUS and REGN stock?

Key differences: Market Cap ($780.84M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-98.9% vs 45.8%).

Popular Stock Comparisons